GI DYNAMICS, INC Provides An Extension Of The Maturity Date Of US $5M Convertible Note

  • Jan 02, 2019 AEDT
  • Team Kalkine
GI DYNAMICS, INC Provides An Extension Of The Maturity Date Of US $5M Convertible Note

GI DYNAMICS, INC (ASX: GID) is to extend the maturity date of its 2017 Senior Secured Convertible Promissory Note from 31 December 2018 to 31 March 2019 and is pleased to announce that it has reached an agreement with Crystal Amber Fund Limited. Essentially the company’s largest shareholder is Crystal Amber.

The company issued on 15 June 2017, the Note to Crystal Amber in the aggregate principal amount of US $5m. The Note accrues interest compounded annually, at a rate of 5% per year. To repay the total amount outstanding under the Note the company does not currently have enough cash reserves. On 16 June 2017, including a summary of its terms, the details of the Note were first time announced by the company.

By 7 January 2019 in exchange for the extension of the maturity date of the Note, the company has agreed to pay to Crystal Amber all outstanding interest that had accrued under the Note until 31 December 2018, the amount of US $393,835.62.

To carry on the evaluation of its optimal capital markets strategy the company plans to use the extended term of the Note, to support a listing on another stock exchange and associated fundraising which includes potentially hiring an investment bank.

To either restructuring the terms of the Note it will continue discussions with Crystal Amber as desirable or as needed in connection with the company’s future capital markets strategy. If the Company is unable to raise enough funds by 31 March 2019, agreeing terms for a further extension of the Note’s maturity date to enable it to repay the Note in full on its maturity date.

To conduct its planned clinical trials in the United States (GID 18-1) and to support the company’s and India continued operation, the company continue to evaluate and pursue sources of raising additional funds.’ They continue to believe EndoBarrier as a potential treatment for patients diagnosed with type 2 diabetes and obesity, and to support the clinical trials approved in the United States and India are working hard to secure additional financing.

GI DYNAMICS, INC (ASX: GID) has surged up by 18.75% to trade at $0.019 as at January 02, 2019 which is very near to its 52-week low.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

 

All pictures are copyright to their respective owner(s).Kalkinemedia.com does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.

 

There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK